OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
Ranakishor Pelluri, S. Kongara, Vanitha Rani Nagasubramanian, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 5, pp. 855-867
Closed Access | Times Cited: 6
Ranakishor Pelluri, S. Kongara, Vanitha Rani Nagasubramanian, et al.
Journal of Endocrinological Investigation (2023) Vol. 46, Iss. 5, pp. 855-867
Closed Access | Times Cited: 6
Showing 6 citing articles:
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
Gu-Lao Zhang, Yuan Liu, Yanfeng Liu, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 4, pp. 724-734
Open Access | Times Cited: 6
Gu-Lao Zhang, Yuan Liu, Yanfeng Liu, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 4, pp. 724-734
Open Access | Times Cited: 6
Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis
Miao Zhu, Ruifang Guan, Guo Ma
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Miao Zhu, Ruifang Guan, Guo Ma
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
An Observational Retrospective Real-World Study to Evaluate the Effect of Teneligliptin on Parameters of Renal Function, Glycemic Control, and Safety in Indian T2DM Patients with Chronic Kidney Disease (TOP RENAL)
Shashank Joshi, Hanmant Barkate, Ashok Kumar Das, et al.
Current Trends in Internal Medicine (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Shashank Joshi, Hanmant Barkate, Ashok Kumar Das, et al.
Current Trends in Internal Medicine (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Teneligliptin alleviates diabetes-related cognitive impairment by inhibiting the endoplasmic reticulum (ER) stress and NLRP3 inflammasome in mice
Wei-Feng Wang, Juanjuan Zhang
Aging (2023)
Open Access | Times Cited: 3
Wei-Feng Wang, Juanjuan Zhang
Aging (2023)
Open Access | Times Cited: 3
Effect of Teneligliptin 20 mg Twice Daily on Glucagon-Like Peptide-1 Levels and Its Influence on Non-Glycemic Components in Non-Diabetic Obese Individuals
Ranakishor Pelluri, Srikanth Kongara, Vanitha Rani Nagasubramanian, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 2, pp. 90-96
Open Access
Ranakishor Pelluri, Srikanth Kongara, Vanitha Rani Nagasubramanian, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 2, pp. 90-96
Open Access
Effect of teneligliptin 20 mg twice daily on glucagon like-peptide-1 (GLP-1) levels and its influence on non-glycemic components in non-diabetic obese individuals
Ranakishor Pelluri, Srikanth Kongara, Vanitha Rani Nagasubramanian, et al.
Research Square (Research Square) (2023)
Open Access
Ranakishor Pelluri, Srikanth Kongara, Vanitha Rani Nagasubramanian, et al.
Research Square (Research Square) (2023)
Open Access
